Skip to main content

Tisotumab Vedotin-tftv

Placeholder slot
 (ty-SOH-too-mab veh-DOH-tin)

This page contains brief information about tisotumab vedotin-tftv and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Tivdak
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Tisotumab vedotin-tftv is approved to treat:

Tisotumab vedotin-tftv is approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that it provides a clinical benefit in these patients.

Tisotumab vedotin-tftv is also being studied in the treatment of other types of cancer.

More About Tisotumab Vedotin-tftv

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Targeted Cancer Therapies

Monoclonal Antibodies

Clinical Trials Accepting Patients

Find Clinical Trials for Tisotumab Vedotin-tftv - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: